Form 4: YD Bio CEO Buys Shares
Insider Transaction (Form 4)
Ethan Shen, CEO and a Director of YD Bio Ltd, purchased 12,700 shares of common stock on September 14, 2026 for $3.85 per share.
Summary
- Open-market purchase: acquired 12,700 Ordinary Shares at $3.85 ($48,895) on September 14, 2026; holds 11,258,331 after (Direct).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $48,895, committing personal capital to the stock.
Insider Transactions
Ethan Shen — Director, Officer (CEO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-14 | Open-market purchase | Ordinary Shares | 12,700 | $4 | $48.9K | 11,258,331 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-14 | Open-market purchase (12,700 shares) |
Keywords
insider transaction, Form 4, YDES, YD Bio Ltd, bullish, Ethan Shen
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.